D.Med Healthcare GmbH & Co. KG and Changshan Pharmaceutical (Hongkong) Co. Ltd., 100% subsidiary of the stock-listed Chinese manufacturer of pharmaceutical products, Hebei Changshan Biomedical Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange / SIN 300255:CH), announce the set-up of a joint venture aiming at the production and marketing of Heparin formulations
D.Med Medical Services GmbH enters into a partnership with India-based Biomed to form German Renal Care Private Limited (GRC)
With a goal to provide affordable dialysis services and training in India while adhering to German and international standards, D.Med Medical Services GmbH entered into a partnership with India-based (Pune) Biomed.Read more
In order to strengthen its role in the production, sales, marketing and further development of the highly innovative Gynedil dilation devices (www.gynedil.com), D.Med Healthcare AG has increased its share in Belgrade-based Inove d.o.o., the manufacturer of Gynedil, from 10 to 54.5% by taking over the shares of the company’s founder Dobrivoje Rajkovic. This deal underlines the importance of the Gynaecology segment in D.Med’s future strategy and will be followed by further steps in this field.
In the course of our expansion strategy in Africa we gladly announce the opening of new D.Med Healthcare sales entities in Kenya, Mozambique and Zimbabwe which will enable us to be even closer to our regional customers and partners and open up new opportunities in these buzzing markets.
With the creation of the D.Sicco GmbH between D.Med Healthcare Germany AG and Sisco Ltd. from India, D.Med Healthcare has integrated the product range of one of the major suppliers of Latex and Silicon Catheters into its group of companies.Read more